Abstract
Objective: In early-stage endometrioid endometrial cancer (EC) patients who are fertile, fertility-sparing therapy is enforced than primary surgical staging. However, there is no consensus for the optimal duration of this treatment. The aim of this study is to determine the duration of fertility-sparing hormone therapy in patients with early-stage endometrioid EC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
